JP2021520352A5 - - Google Patents

Info

Publication number
JP2021520352A5
JP2021520352A5 JP2020554077A JP2020554077A JP2021520352A5 JP 2021520352 A5 JP2021520352 A5 JP 2021520352A5 JP 2020554077 A JP2020554077 A JP 2020554077A JP 2020554077 A JP2020554077 A JP 2020554077A JP 2021520352 A5 JP2021520352 A5 JP 2021520352A5
Authority
JP
Japan
Prior art keywords
composition according
nanoparticles
biological polymer
composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020554077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021520352A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025782 external-priority patent/WO2019195546A1/en
Publication of JP2021520352A publication Critical patent/JP2021520352A/ja
Publication of JP2021520352A5 publication Critical patent/JP2021520352A5/ja
Priority to JP2023124313A priority Critical patent/JP2023133446A/ja
Pending legal-status Critical Current

Links

JP2020554077A 2018-04-04 2019-04-04 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法 Pending JP2021520352A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023124313A JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652548P 2018-04-04 2018-04-04
US62/652,548 2018-04-04
PCT/US2019/025782 WO2019195546A1 (en) 2018-04-04 2019-04-04 Self-assembled gels for controlled delivery of biologics and methods of making thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023124313A Division JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Publications (2)

Publication Number Publication Date
JP2021520352A JP2021520352A (ja) 2021-08-19
JP2021520352A5 true JP2021520352A5 (https=) 2022-04-11

Family

ID=66248685

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554077A Pending JP2021520352A (ja) 2018-04-04 2019-04-04 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法
JP2023124313A Pending JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023124313A Pending JP2023133446A (ja) 2018-04-04 2023-07-31 生物製剤の制御送達用の自己組織化ゲルおよびその製造方法

Country Status (6)

Country Link
US (2) US20190307885A1 (https=)
EP (1) EP3773478A1 (https=)
JP (2) JP2021520352A (https=)
AU (2) AU2019247375B2 (https=)
CA (1) CA3096745A1 (https=)
WO (1) WO2019195546A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013008697A2 (pt) 2010-09-24 2016-06-21 Massachusetts Inst Technology géis nanoestruturados capazes de liberação controlada de agentes encapsulados
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
CA3113948A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
IL301609A (en) * 2020-10-01 2023-05-01 Standard Millox Pharmaceuticals Oy Hydrogel material
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2278999B1 (en) * 2008-04-21 2025-01-29 Dompé farmaceutici S.p.A. Auris formulations for treating otic diseases and conditions
US8759322B2 (en) * 2008-11-05 2014-06-24 National University Corporation Tokyo Medical And Dental University Hyaluronic acid derivative and pharmaceutical composition thereof
JP5675798B2 (ja) * 2009-07-09 2015-02-25 ポリマーズ シーアールシー リミテッドPolymers CRC Ltd. バイオポリマーハイブリッドゲルデポー送達システム
EP3409289B1 (en) 2010-02-26 2020-09-30 Novo Nordisk A/S Stable antibody containing compositions
BR112013008697A2 (pt) * 2010-09-24 2016-06-21 Massachusetts Inst Technology géis nanoestruturados capazes de liberação controlada de agentes encapsulados
HK1218858A1 (zh) * 2013-03-14 2017-03-17 麻省理工学院 用於长时间持续释放人类抗体的多层可注射自组装肽脚手架水凝胶
EP3448427A1 (en) 2016-04-29 2019-03-06 CureVac AG Rna encoding an antibody
CA3062885C (en) * 2016-05-06 2022-03-29 The Brigham And Women's Hospital, Inc. Self-assembled gels for controlled delivery of biologics and labile agents
WO2018007327A1 (en) 2016-07-08 2018-01-11 Atonomics A/S A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
GB2552473A (en) 2016-07-21 2018-01-31 Evox Therapeutics Ltd Surface decoration of extracellular vesicles
HRP20260151T1 (hr) 2016-08-02 2026-03-27 Visterra, Inc. Modificirani polipeptidi i njihova uporaba
WO2018031954A1 (en) 2016-08-12 2018-02-15 Biogen Ma Inc. Identifying components of dry powder mixtures using raman spectroscopy
CN109843929B (zh) 2016-08-23 2024-07-05 加利福尼亚大学董事会 蛋白水解可切割的嵌合多肽及其使用方法

Similar Documents

Publication Publication Date Title
JP2021520352A5 (https=)
CN113041356B (zh) 血筒素靶向载药体系、制备方法及其应用
US20230364014A1 (en) Self-assembled gels for controlled delivery of biologics and methods of making thereof
CN103374128B (zh) 两亲性三嵌段共聚物、聚合物纳米载体制剂及制备方法
CN103251561B (zh) 一种双敏感可崩解式纳米囊泡药物载体制剂及其制备方法
CN103432582B (zh) 一种rgd靶向卟啉聚合物纳米胶束的制备方法
CN105617362B (zh) 一种新型的胰岛素-磷脂-壳聚糖自组装微粒载体及其制剂
KR20170106460A (ko) 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
CN111450258B (zh) 一种促进蛋白药物跨黏液渗透的口服给药系统及其制备
CN104817660A (zh) 一种改性羧甲基壳聚糖纳米凝胶的制备
WO2017193138A1 (en) Self-assembled gel for controlled delivery of thermolabile agents
JP2019516689A5 (https=)
CN110448543A (zh) 一种基于埃洛石纳米管/壳聚糖复合骨架的绿原酸肠溶缓释微球及其制备方法
CN111904945A (zh) 一种纳米混悬液的口服给药体系和构建方法及其应用
CN102908332A (zh) 用于口服胰岛素递送的包含阳离子纳米粒子的肠溶包衣胶囊
CN102641245B (zh) 一种装载难溶性药物的壳聚糖-壳聚糖衍生物纳米球、制备方法及其作为口服制剂的应用
CN104490847B (zh) 一种热变性制备稳定白蛋白纳米颗粒的方法
JP2022103299A (ja) 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
CN103239729A (zh) 含超支化聚合物与磷脂的纳米载体及其制备方法和应用
CN110214145B (zh) CP-iRGD多肽、iDPP纳米粒、载药复合物及其制备方法和应用
CN111743880B (zh) 一种单抗类药物口服纳米-微球制剂及其制备方法
CN103120797B (zh) 还原响应的纳米药物载体、纳米药物颗粒与纳米药物颗粒制剂及其制备方法
CN108379241A (zh) 胆甾醇疏水改性普鲁兰-多奈哌齐-聚山梨酯80纳米粒子及制备和应用
CN118767149A (zh) 一种细菌外膜囊泡包裹紫杉醇纳米粒的药物载体及其制法
JP2020519635A5 (https=)